Drugs Controller General of India (DCGI) has directed Serum Institute of India to suspend till further orders new recruitment in phase 2 and 3 clinical trials of the Oxford COVID-19 vaccine candidate...
from NDTV News - Topstories https://ift.tt/2Fksy5W
Subscribe to:
Post Comments (Atom)
In Setback To Vedanta, Law Tribunal Rejects Plea Against Adani In JAL Case
Vedanta had challenged the approval of Adani Group's resolution plan by the Committee of Creditors (CoC) in the Jaiprakash Associates in...
-
Zohran Mamdani, a 33-year-old democratic socialist, has been the presumptive favorite in the election since soundly beating former Gov. Andr...
-
Continuing his attacks against on media, US President Donald Trump on Sunday described himself as the "hardest working president",...
-
All eyes will be on Virat Kohli on the occasion of his 100th Test match when India take on Sri Lanka in the first of a two-match Test series...
No comments:
Post a Comment